TG Therapeutics(TGTX)
NEW YORK, NYBiotechnology
Focus: TG Therapeutics is a publicly traded biotech company focused on biologics for oncology, neurology, and immunology, with a diversified pipeline anchored by one commercial product.
Profile data last refreshed 19h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About TG Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow TG Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Late-stage
7 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$234M
Key Products
Growing
Peak9.1yr
Sole marketed product driving FY2025 $234M revenue; exclusivity extends to 2035, providing long-term cash generation runway.
Help build intelligence for TG Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.